Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-10.47%Return on Equity
VS
Market
Sector
Industry
History
$ 3.56Close
$ 1.06 - $ 6.77 52-Week Range
Ticker Information
Ticker
CPIXCompany Name
CUMBERLAND PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQCUMBERLAND PHARMACEUTICALS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CPIX - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 27.99M | $ -2.93M | -10.47% |
| 3/31/2025 | $ 28.66M | $ -3.28M | -11.43% |
| 12/31/2024 | $ 22.85M | $ -6.48M | -28.35% |
| 9/30/2024 | $ 24.78M | $ -10.87M | -43.87% |
| 6/30/2024 | $ 26.35M | $ -10.38M | -39.38% |
| 3/31/2024 | $ 27.49M | $ -8.42M | -30.62% |
| 12/31/2023 | $ 29.6M | $ -6.28M | -21.21% |
| 9/30/2023 | $ 35.99M | $ -2.43M | -6.74% |
| 6/30/2023 | $ 37.16M | $ -1.78M | -4.8% |
| 3/31/2023 | $ 36.36M | $ -3.99M | -10.98% |
Key Performance Insights, Last 5 Years
- CUMBERLAND PHARMACEUTICALS INC's latest trailing twelve months (TTM) ROE stands at -7.13%.
- Over the past 5 years, CUMBERLAND PHARMACEUTICALS INC's average ROE has been -15.05%.
- The median ROE for CUMBERLAND PHARMACEUTICALS INC during this period was -11.21%
- CUMBERLAND PHARMACEUTICALS INC reached its highest ROE over the past 5 years at 0.06%.
- The lowest ROE recorded by CUMBERLAND PHARMACEUTICALS INC in the same timeframe -43.87%
CUMBERLAND PHARMACEUTICALS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for CUMBERLAND PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -3.42M ] / Equity [ $ 47.93M ]
(=) ROE [ -7.13% ] CPIX - Return on Equity, Last 5 years
-43.87%
Minimum
Sep 30, 2024
0.06%
Maximum
Jun 30, 2021
-15.05%
Average
-11.21%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.68%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.68% |